FilingReader Intelligence
COFCO Biotechnology achieves profitability, expands green initiatives
April 25, 2025 at 05:44 PM UTC•By FilingReader AI
COFCO Biotechnology (SZSE:000930) released its 2024 Annual Financial Report and related announcements, showcasing a turnaround in profitability alongside significant strides in sustainable practices and strategic initiatives. In 2024, the company achieved total revenue of CNY 20.05 billion, with net profits attributable to shareholders reaching CNY 25.13 million, compared to a loss of CNY 601.63 million the previous year.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
The company's 2024 annual financial reportApril 25, 2025 at 10:27 AM UTC
2024 Annual ReportApril 25, 2025 at 10:27 AM UTC
2024 Annual Audit ReportApril 25, 2025 at 10:27 AM UTC
2024 Annual Report SummaryApril 25, 2025 at 10:27 AM UTC
Annual special audit report on related party funds misappropriationApril 25, 2025 at 10:27 AM UTC
2024 Annual Report of the Board of DirectorsApril 25, 2025 at 10:27 AM UTC
Internal Control Audit ReportApril 25, 2025 at 10:27 AM UTC
2024 Annual Report on the Performance of the Audit Committee of the Board of DirectorsApril 25, 2025 at 10:27 AM UTC
Announcement on the Provision for Asset Impairment in 2024April 25, 2025 at 10:27 AM UTC
Announcement on Repurchasing and Cancelling Part of Restricted Stocks to Reduce Capital and Notify CreditorsApril 25, 2025 at 10:27 AM UTC
Announcement on the Proposal of Not Distributing Profits in 2024April 25, 2025 at 10:27 AM UTC
Announcement on Reducing Registered Capital and Amending the Articles of AssociationApril 25, 2025 at 10:27 AM UTC
2024 Annual Report of the Board of SupervisorsApril 25, 2025 at 10:27 AM UTC
Announcement on the Failure to Achieve the Unlocking Conditions of the Fourth Unlocking Period of the Company's Restricted Stock Incentive Plan and the Repurchase and Cancellation of Part of the Restricted StocksApril 25, 2025 at 10:27 AM UTC
2024 ESG ReportApril 25, 2025 at 10:27 AM UTC
Risk Assessment Report on Deposits, Loans and Other Financial Businesses Related to the Company and COFCO Finance Co., Ltd.April 25, 2025 at 10:27 AM UTC
Special statement on deposits, loans and other financial businesses involving related-party transactions of financial companies in 2024April 25, 2025 at 10:27 AM UTC
SZSE:000930•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when COFCO Biotechnology publishes news
Free account required • Unsubscribe anytime